LARP4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.426800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.903400E-01
Normal-vs-Stage2
9.354800E-01
Normal-vs-Stage3
1.046170E-02
Normal-vs-Stage4
6.348800E-01
Stage1-vs-Stage2
6.227600E-01
Stage1-vs-Stage3
1.108070E-02
Stage1-vs-Stage4
9.823800E-01
Stage2-vs-Stage3
6.16589999999917E-05
Stage2-vs-Stage4
7.022600E-01
Stage3-vs-Stage4
2.009700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.528800E-01
Normal-vs-AfricanAmerican
5.970200E-01
Normal-vs-Asian
6.623800E-01
Caucasian-vs-AfricanAmerican
3.147400E-01
Caucasian-vs-Asian
3.238800E-01
AfricanAmerican-vs-Asian
2.240600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.425400E-01
Normal-vs-Female
9.250800E-01
Male-vs-Female
2.513800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.360600E-01
Normal-vs-Age(41-60Yrs)
5.479800E-01
Normal-vs-Age(61-80Yrs)
8.398400E-01
Normal-vs-Age(81-100Yrs)
6.139600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.972200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.405800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.360200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.437600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.870000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.666600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.548000E-01
Normal-vs-Daily Drinker
4.379800E-01
Normal-vs-Weekly Drinker
7.732000E-01
Normal-vs-Occasional Drinker
6.203400E-01
Normal-vs-Social Drinker
7.033400E-01
Non Drinker-vs-Daily Drinker
8.068200E-01
Non Drinker-vs-Weekly Drinker
5.614000E-01
Non Drinker-vs-Occasional Drinker
4.450000E-02
Non Drinker-vs-Social Drinker
3.928100E-02
Daily Drinker-vs-Weekly Drinker
4.913000E-01
Daily Drinker-vs-Occasional Drinker
3.876100E-02
Daily Drinker-vs-Social Drinker
4.653500E-02
Weekly Drinker-vs-Occasional Drinker
1.889780E-01
Weekly Drinker-vs-Social Drinker
2.807400E-01
Occasional Drinker-vs-Social Drinker
6.838400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.955180E-01
Normal-vs-Grade 2
1.897620E-01
Normal-vs-Grade 3
1.081380E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.251800E-01
Grade 1-vs-Grade 3
7.903600E-01
Grade 1-vs-Grade 4
1.955180E-01
Grade 2-vs-Grade 3
5.161800E-01
Grade 2-vs-Grade 4
1.897620E-01
Grade 3-vs-Grade 4
1.081380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.179800E-01
Normal-vs-NonDiabetic
9.251600E-01
Diabetic-vs-NonDiabetic
4.766000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.395400E-01
Normal-vs-NoPancreatitis
9.427200E-01
Pancreatitis-vs-NoPancreatitis
3.975000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.229400E-01
Normal-vs-N1
9.142200E-01
N0-vs-N1
4.885400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.542400E-01
Normal-vs-TP53-NonMutant
7.782800E-01
TP53-Mutant-vs-TP53-NonMutant
7.655200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
